Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy.

Saved in:
Bibliographic Details
Title: Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy.
Authors: Magavern EF; William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK. e.magavern@qmul.ac.uk., Dan GA; Carol Davila University of Medicine, Academy of Romanian Scientists, Bucharest, Romania., Savarese G; Department of Clinical Science and Education, Södersjukhuset; Karolinska Institute, Stockholm, Sweden., Borghi C; Department of Cardiovascular Medicine, University of Bologna-IRCCS AOU S. Orsola, Bologna, Italy., Dobrev D; Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany.; Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Canada.; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA., Tamargo J; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense, Madrid, Spain., Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; Center for Pharmacology and Drug Research and Development, Semmelweis University, Budapest, Hungary.; Pharmahungary Group, Szeged, Hungary., McDermott JH; Division of Evolution, Infection and Genomics, School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK., Newman WG; Division of Evolution, Infection and Genomics, School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK., Pirmohamed M; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, L69 3GL, UK., Caulfield MJ; William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK., Kaski JC; Cardiovascular and Genomics Research Institute, St George's, University of London, London, SW18 0RE, UK.
Source: The pharmacogenomics journal [Pharmacogenomics J] 2026 Apr 23; Vol. 26 (3). Date of Electronic Publication: 2026 Apr 23.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Electronic Cited Medium: Internet ISSN: 1473-1150 (Electronic) Linking ISSN: 1470269X NLM ISO Abbreviation: Pharmacogenomics J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-1150
DOI:10.1038/s41397-026-00412-6